Zydus Lifesciences Limited — Call Transcript 2020

Jun 17, 2020

==> picture [94 x 47] intentionally omitted <==

==> picture [68 x 50] intentionally omitted <==

BSE Limited1stFloor, P. J. TowersDalal StreetMumbai–400 001Kind Attn.:Code:Mr. Sanjay Golecha /Mr. Gopalkrishnan532321		National Stock Exchange of India LimitedExchange Plaza, 5thFloor,Plot No. C/1, G Block,Bandra-Kurla Complex, Bandra (East)Mumbai–400 051Kind Attn.:Symbol:Famroze PocharaAsst. Vice PresidentCADILAHC
Date:June 17,2020
Sub.:Schedule of Analyst/Institutional Investors’ meet

Dear Sir / Madam

Pursuant to regulation 30 of the SEBI [Listing Obligations and Disclosure Requirements] Regulations, 2015, we hereby inform that the Company has planned investor interaction through a conference call on June 19, 2020 at 3.00 p.m., post announcement of audited financial results for the quarter / year ended on March 31, 2020.

Thanking you,

Yours faithfully, For, CADILA HEALTHCARE LIMITED

DHAVAL Digitally signed by DHAVAL NARENDRA SONI NARENDRA SONI Date: 2020.06.17 15:36:05 +05'30' DHAVAL N. SONI COMPANY SECRETARY

Regd. Office: “Zydus Corporate Park” Scheme No. 63, Survey No. 536, Khoraj (Gandhinagar), Nr.Vaishnodevi Circle, S.G. Highway, Ahmedabad – 382481. Phone: +91-07971800000, +91-79-48040000 www.zyduscadila.com CIN : L24230GJ1995PLC025878